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 In a normal pregnancy the immune system plays the critical task of 
protecting the fetus from the constant threat posed by pathogens while limiting the 
effects of the mother’s immune response on the fetus itself. Viral and bacterial 
infections can cause preterm labor and intrauterine growth restriction, and the 
placental trophoblasts express pattern recognition receptors (PRRs) to help detect 
invading pathogens and initiate an effective immune response. Chlamydia 
trachomatis (Ct) is the most common sexually transmitted bacterial infection in 
the United States and can infect the decidua and placenta. Chlamydia infection of 
first trimester placental trophoblasts induces a change in the cytokines and 
chemokines present at the maternal-fetal interface and results in production of the 
pro-inflammatory cytokine interlukin-1β (IL-1β). We hypothesize that the IL-1β 
response is mediated through toll-like receptor 2 (TLR-2) for transcription, and 
inflammasome forming Nod-like receptors (NLRP-3 or IPAF) for its processing 
and secretion. Our work in the trophoblast cell lines H8 and Sw.71 demonstrated 
that Ct induces the transcription of IL-1β mRNA and translation of intracellular 
pro-IL-1β as early as 12h, and the secretion of active-IL-1β starting at 24h post 
infection. The induction of IL-1β is independent of MyD88, as there was no 
change in IL-1β production when we blocked MyD88 by using dominant-
negative (DN) MyD88 cells. The production of IL-8 and IL-6 by trophoblasts 
after Ct infection is mediated through MyD88 and TLRs as described in other cell 
types, which confirms that our DN-MyD88 system is functional. Further we 
demonstrated that preventing NALP-3 inflammasome activation by blocking 
potassium (K+) efflux from cells partially inhibited IL-1β secretion in both H8 and 
Sw.71 cells. This suggests a role for NLRP-3 inflammasome in mediating the 
processing and secretion of IL-1β. In summary we have shown that Chlamydia is 
able to act through different pathways to affect its host. It can induce IL-1β 
transcription through PRRs in a MyD88 independent manner, it can potentially 
induce the processing of pro-IL-1β through the NALP-3 inflammasome, and it 
can stimulate the secretion of active-IL-1β from the cells. The presence of 
Chlamydia trachomatis in the placenta, and the many mechanisms it uses to 
modulate the immune system, like IL-1β secretion, can result in negative 
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 Chlamydia trachomatis (Ct) is a gram negative obligate intracellular 
bacterium that affects an estimated 90 million people per year worldwide. In the 
United States Chlamydia is the most common sexually transmitted bacterial 
infection and the Centers for Disease Control and Prevention (CDC) estimate up 
to 3.5 million asymptomatic infections per year. Despite the fact that almost half 
of these infections are thought to spontaneously clear, they still have a large 
public health impact [1]. The best estimate of Chlamydia prevalence is 7.4%, with 
the highest rates among young sexually active women between the ages of 15 and 
24. The majority of women that have Chlamydia infections, up to 60-70%, are 
asymptomatic and thus do not seek treatment [1]. Both symptomatic and 
asymptomatic disease however, can have a negative impact on a woman’s 
reproductive potential, with up to 40% resulting in pelvic inflammatory disease 
(PID), which can lead to infertility and ectopic pregnancies [2]. Intrauterine 
bacterial or viral infections have also been associated with pregnancy 
complications such as preterm labor, intrauterine growth restriction (IUGR) and 
pre-eclampsia [3]. Moreover there is evidence indicating that Chlamydia infection 
can be associated with pregnancy complications like still birth, spontaneous 
abortion and prematurity [4]. 
 Chlamydia trachomatis exists as multiple serologically distinct serovars 
[5]. The ocular serovars A–C cause ocular trachoma which is the most common 
cause of preventable blindness wordwide; serovars D–K infect the urogenital 
tract; and serovars L1–L3 cause Lymphogranuloma Venerium [6]. Ct primarily 
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infects epithelial cells of the eye and genital tract, but it can also invade a wide 
range of other cell types including monocytes, dendritic cells, fibroblasts and 
endothelial cells. In addition, some clinical studies have demonstrated that Ct is 
present in the placenta and decidua [5, 7-9]. Chlamydia invades cells as a 
metabolically inert elementary body (EB) and once inside the cytoplasm starts 
transforming its endocytic vesicle into an inclusion (a special vesicle containing 
host lipids and Ct proteins). The EBs differentiate into the non-infectious but 
metabolically active reticuloid bodies (RBs) and start replicating within the 
inclusion. After replication, the RBs re-differentiate into EBs and get released 
from the host cell by cell lysis or exocytosis at approximately 2-3 days after 
infection and proceed to infecting the neighboring cells [10]. 
 Chlamydia trachomatis has many mechanisms to evade or modulate the 
immune system. The bacterium has antigenically diverse surface proteins, but 
because it replicates within a membrane bound inclusion it helps it avoid 
detection.  During an infection Chlamydia can also modify the host cell and the 
immune response by secreting virulence factors through a type III secretion 
system. Some factors prevent the fusion of the inclusion with lysosomes, they 
block or down-regulate the caspases involved in apoptosis and secrete proteases 
(CPAF) that degrade transcription factors needed for the up-regulation of MHC 
class I and II. Moreover, another protease encoded by the CT441 gene cleaves the 
NFkB p65 and interferes with the NFkB signaling pathway that is downstream of 
some of the immune receptors involved in pathogen recognition [1]. Chlamydia 
trachomatis infection of human immune cells can lead to the generation of an 
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inflammatory immune response through the production of cytokines and 
chemokines like IL-6, IL-8, IL-1 and IL-18 [24, 30-32]. 
 The maternal-fetal interface at the level of the placenta serves as an active 
barrier against microorganisms and is thought to involve primarily the innate 
immune system. The majority of the immune cells present in the placenta in the 
first trimester are NK cells (70%), non-inflammatory macrophages (20-25%) and 
dendritic cells (~2%), which promote trophoblast invasion and spiral artery 
remodeling needed for a successful placentation [11]. Placental trophoblasts also 
have the ability to sense pathogens and have been shown to express pattern 
recognition receptors (PRRs), like Toll-like receptors (TLRs) and NOD-like 
receptors (NLRs), which recognize highly conserved molecules on pathogens 
known as pathogen-associated molecular patterns (PAMPs) [11-12]. In humans 
10 TLRs have been identified so far, and they are expressed on mononuclear, 
endothelial, epithelial and trophoblast cells. TLRs are transmembrane proteins 
which recognize PAMPs like bacterial lipopolysaccharide (LPS), petidoglycan, 
flagellin, lipoproteins or viral dsRNA. Upon binding of their ligands, they signal 
through the adapter protein MyD88 to activate the NFkB or MAPK pathways and 
thus induce the transcription of genes encoding for cytokines and chemokines 
[13-14]. Through these receptors, the trophoblasts can initiate a pro-inflammatory 
innate immune response. This will recruit immune cells at the site of infection, 
trigger the adaptive immune system and protect the fetus [7,15].  
 The trophoblast cells are unique in that they constitutively secrete an array 
of cytokines and chemokines that ensure the proper immune cell balance in the 
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uterus to maintain a healthy pregnancy. The activation of TLR-4 in trophoblasts 
by binding of LPS induces the up-regulation of their constitutive secretion of 
cytokines and chemokines like IL-8, MCP-1, GROα, RANTES. This response is 
involved in the migration of NK cells, monocytes and PMNs to the placental 
interface [11-12]. The increased presence of these inflammatory cytokines and 
immune cells was seen in placentas from preterm deliveries and are thought to 
have triggered the parturition [16]. Chlamydia has been shown to activate TLR-4 
and TLR-2 in macrophages and dendritic cells [17]. The chlamydial LPS is 
weakly endotoxic and while it is able to stimulate TLR-4, in animals it does not 
lead to a change in infection clearing. However, TLR-2 plays a larger role in 
initiating an inflammatory response [18]. TLR-2 has been shown to recognize 
chalmydial LPS [19] and in genital tract epithelial cells infected with Chlamydia, 
TLR-2 and its adapter protein MyD88 were shown to be recruited to the 
chlamydial inclusion membrane and be required for the production of IL-8, a 
potent neutrophil attractant [20]. Studies in TLR-2 knockout mice showed greatly 
reduced pathology after Chlamydial infections compared to the wild type animals 
suggesting a role for TLR-2 in mediating the immune response to this pathogen 
[17]. 
 The pro-inflammatory immune responses to Chlamydia infections in 
cervical epithelial cells that leads to the production of IL-1β, IL-8, IL-6 and 
GROα does not always occur until a day after the initial infection when the 
organisms is already inside the cell [21]. This suggests that intracellular PRRs like 
the NLRs could also sense the presence of the pathogen and play a role in the 
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immune response. One family of NLRs is the NOD (nucleotide-binding 
oligomerization domain) proteins which are a general cytosolic sensor of gram 
positive and gram negative bacteria. NOD proteins recognize peptides derived 
from peptidoglycan and activate the NFkB and MAP-kinase pathways which 
result in an inflammatory response [11].  NOD1 generally detects meso-
diaminopimelic acid (meso-DAP), which is present in gram negative bacteria 
while NOD2 detects muramyl-dipeptide (MDP), a large motif common to both 
gram positive and gram negative bacteria [22].  
 First trimester trophoblast cells have been shown to express both NOD1 
and NOD2 and after stimulation with MDP, the common NOD-2 ligand, the 
trophoblasts up-regulate their production of the pro-inflammatory cytokines IL-6, 
IL-8, MCP-1, GROα and RANTES [12]. A similar response is seen when 
trophoblasts are stimulated with the NOD1 agonist iC-DAP, which proves that the 
NOD receptors are functional in these cells [12]. The trophoblasts also up-
regulate their expression of NOD1 and NOD2 via the NFkB pathway when TLR-
4 is stimulated with bacterial LPS [23]. NOD1 and NOD2 have also been 
implicated in the recognition of Chlamydia [21], and as described above at least 
two of the TLRs (TLR-2 and TLR-4) are involved in mediating an immune 
response to Chlamydia infections [19-20]. These findings come to suggest that 
there is a tight connection between the roles of TLRs and NODs in recognizing 
Chlamydia trachomatis, and that they might work together in mounting an 
effective immune response.  
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 Another class of NLRs potentially involved in detecting invading bacteria 
is the NLR proteins. The NALPs like the NALP1, NALP3 and NLRC4 (IPAF) 
have leucine rich repeats (LRR) able to recognize bacterial toxins, pathogen 
PAMPs and danger signals like free ATP resulting from cellular damage. Upon 
activation, NALPs assemble into "inflammasomes". The inflammasomes are 
multi-protein complexes composed of ASC (apoptosis-associated speck-like 
protein containing a caspase recruitment domain) a sensing NLR protein and pro-
caspase-1, which lead to the activation of the inflammatory caspases-1. NALPs 
oligomerize through their NACHT domains and associate with the adapter protein 
ASC via the PYD region [22]. ASC in turn contains a CARD domain, which 
recruits pro-caspase-1 and leads to its dimerization and activation [22]. While the 
exact signals for the assembly of NALP inflammasomes are still being worked 
out, it appears that K+ efflux from the cells and formation of ROS is a common 
trigger for NALP1 and NALP3 inflammasomes [24].  Unlike the NALP1 and 
NALP3, the NLRC4 (IPAF) inflammasome is known to sense virulence factors 
from gram negative bacteria, and can activate caspase-1 even in the absence of 
ASC [22].  
 Caspase-1 (also known as interleukin-1 converting enzyme or ICE) is a 
cysteine protease composed of 2 subunits (10kDa and 20kDa) present in cells as 
an inactive zymogen. After activation it has been shown to process the cytokines 
pro-IL-1β, pro-IL-18 and pro-IL-33 into their active forms [25]. Caspase-1 
activation occurs in HeLa epithelial cells after Chlamydia infection, but it was not 
until recently that it was shown that this activation was dependent on the NALP3 
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inflammasome [26]. Caspase-1 activation and IL-1β production in response to 
Chlamydia infection was also shown in macrophages, monocytes and dendritic 
cells [24]. 
 IL-1β is one of the most important mediators of inflammation in response 
to infections, and it has also been found to be implicated in autoimmune disorders 
and even Alzheimer’s disease [27]. IL-1β has multiple beneficial roles including 
mediating host responses to microbial invasion, like fever and transmigration of 
leukocytes into the tissues, but also promotes tissue damage and tumor 
invasiveness. In pregnancy IL-1β is associated with initiation of labor and its 
early up-regulation presence at the maternal-fetal interface due to infections could 
result in preterm birth [28]. Most of the cells that usually express IL-1β do not do 
so in a constitutive manner. The mRNA and protein production results from 
stimulation of either TLRs or NODs and is tightly controlled [27]. Thus the 
activation of pro-IL-1β into its biologically active form by caspase-1 and its rapid 
secretion is thought to involve a second stimulus [27]. This requirement suggests 
that more than one receptor such as TLRs and/or NLRs are involved in the 
production and secretion of IL-1β. The messages from these 2 signaling pathways 
would have to be integrated before the release of this highly potent inflammatory 
cytokine.  
 Previous work performed in our laboratory de la Torre et al. (2009)[1] 
showed that Chlamydia trachomatis serovar D infects first trimester placental 
trophoblast cells (HTR-8 and Sw.71 cell lines) and alters the milieu of cytokines 
and chemokines secreted by the trophoblasts [1]. It was observed that both the 
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HTR8 and the Sw.71 trophoblast cell lines up-regulated the secretion of IL-1β, 
IL-8, IL-6 and down-regulated the secretion of MCP-1 (CCl2), GROα, and 
RANTES in response to Chlamydia infection [1]. Moreover there was minimal 
cell death noticed initially in the infected trophoblasts that is consistent with 
previous work reporting that Chlamydia inhibited apoptosis [1].  These changes in 
the cytokine levels could have an effect on the types of immune cells recruited to 
the maternal-fetal interface, which could play a role in causing pregnancy 
complications.  PRRs like TLRs (TLR-2, TLR-4) and NLRs (NOD1, NOD2, 
NALP1 and NALP3) are expressed in the trophoblast cells, and responses to 
Chlamydial infections in other cell types seem to be mediated through both TLRs 
and NLRs. We would like to investigate the possible roles of TLR2, TLR4 and 
the NALP3 inflammasome in mediating the IL-1β production seen after 
trophoblast infection with Chlamydia trachomatis. Our goal of the project for the 




 Chlamydia trachomatis infection of first trimester placental trophoblasts 
induces a change in the immune cytokines and chemokines present at the 
maternal-fetal interface and results in production of the pro-inflammatory 
cytokine IL-1β. We hypothesize that the IL-1β response is mediated through the 
pattern recognition receptors TLR-2 or TLR-4 for transcription, and the NLRP-3 




Specific Aims  
 
1. Investigate which PRRs are activated and play a critical role in the secretion of 
the inflammatory cytokine IL-1β upon Chlamydia trachomatis infection of 
placental trophoblasts. Explore the roles of TLRs (TLR-2 and TLR-4) through 
inhibition of their adapter protein MyD88. 
  
2. Study the role of inflammasomes in the pro-inflammatory immune response 
(IL-1β secretion) to Chlamydia trachomatis infection. Investigate if Chlamydia 
infection leads to an increase in caspase-1 activation, and examine if NLAP-3 and 
the adapter ASC play a role in the IL-1β production.  
 
Materials and Methods 
Cell lines 
 We used two human first trimester trophoblast cell lines. The SV40-
transformed HTR8 cells (referred to as H8) were a gift from Dr. C. Graham 
(Queens University, Kingston, Ontario, Canada), and the Sw.71 cells, were 
immortalized by telomerase-mediated transformation. The H8 cells were 
maintained in RPMI 1640 (GIBCO-Invitrogen) and the Sw.71 cells were grown in 
high-glucose DMEM (GIBCO-Invitrogen). Both media were supplemented with 
10% FBS (HyClone), 10 mM HEPES, 0.1 mM MEM nonessential amino acids, 1 
mM sodium pyruvate, and 100 U/ml penicillin/streptomycin (GIBCO-Invitrogen). 
The human-derived cervical carcinoma cell line HeLa was obtained from 
American Type Culture Collection and was grown in Iscove’s modified high-
glucose DMEM supplemented with 10% FBS, 1% nonessential amino acids 
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(GIBCO-Invitrogen).  The human 293T human embryonic kidney cell line, a gift 
from Dr. Jim Riley (Univ. of Pennsylvania, Philadelphia, PA) was maintained in 
DMEM supplemented with 10%FBS, 2mM glutamine and 100U/ml 
penicillin/streptomycin (GIBCO-Invitrogen). All cell lines were maintained at 
37°C/5% CO2.  
Generation of stably transfected cell lines 
 H8 cells were stably transfected with the pDeNy expression plasmid 
containing human DN-MyD88 (dominant negative) (InvivoGen #pdn-hmyd88). 
The DN-MyD88 (aa 161-296) contains a truncated form of MyD88 that contains 
the C-terminal TIR domain but lacks the death domain and is unable to 
homodimerize and activate the signaling cascade.  2x105 H8 trophoblast cells 
were seeded in a T25 flask in 4 mL RPMI +10% FBS and allowed to attach 
overnight, then washed with serum free OptiMEM (Gibco-Invitrogen). Cells were 
transfected for 18h with 2µg of DNA using the Fugene 6 transfection reagent 
(Roche Diagnostics) in a 1to 3 ratio in 3 mL OptiMEM. Following transfection 
the cells were allowed to recover for 24h in RPMI growth media, then selection 
for stable expression was initiated. The cells expressing DN-MyD88 or DN-ASC 
were selected for using Zeocin (InvivoGen #ant-zn) at 1000µg/mL for 10-14 
days. Untransfected cells served as wild-type controls.  Further, the antibiotic 
selected cells were seeded in 48-well plates at 1 cell/well concentration. The 
plates were screened for single cell colonies under a microscope and further 
cultured in RPMI with Zeocin at 500µg/mL for maintenance. The DN-Myd88 
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individual clones were further tested for IL-8 activity, which served as a 
functional selection marker (IL-8 is MyD88 dependent).  
Real time PCR 
 Total RNA was isolated from cells using the RNeasy Mini Prep kit from 
Qiagen following the manufacturer’s protocol. Reverse transcription of the RNA 
into cDNA was done on 5µg of total RNA using the Sprint RT Complete Oligo 
(dT)18 kit from Clontech following the manufacturer’s protocol (incubate at 70°C 
for 10 min then at 42°C for 1h). Real-time RT-PCR was performed using 
commercially available Applied Biosystems probes for IL-1β (Hs00174097_m1) 
and the control GAPDH (Hs99999905_m1), Taqman Universal Mastermix, and a 
Thermal Cycler (iQ5; Bio-Rad Laboratories, Hercules, CA). Samples were 
analyzed in duplicate and the target gene expression was normalized to that of 
GAPDH. 
Cell Viability Assays            
 The effects of increased extra-cellular potassium (K+) on wild-type H8 and 
Sw.71 trophoblast cell viability were determined using the CellTiter 96 viability 
assay (Promega) following the manufacturer’s protocol. Cell lines were plated in 
96-well plates at 1 x 104 cells/well in growth medium and cultured overnight. The 
medium was then replaced with serum-free Opti-MEM (Invitrogen) or Opti-
MEM+ 50, 70 or 90mM KCl and the cells were cultured for 36h.  The CellTiter 
96 substrate was added to all wells and following 1-2h incubation at 37°C, ODs 
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were read at 490 nm. All samples were assayed in triplicate and cell viability was 
presented as a percentage relative to the untreated control. 
Chlamydia trachomatis culture and stock preparation 
 Chlamydia trachomatis (Ct) serovar D rif-r was a gift from Dr. Robert 
DeMars (University of Wisconsin, Madison, WI). Ct was propagated in HeLa 
cells grown in antibiotic-free DMEM (GIBCO-Invitrogen) as previously 
described. Briefly, HeLa cells were seeded in T75 cm2 flasks (Falcon; BD 
Biosciences) (80% confluency) and allowed to attach overnight. The cells were 
treated with DEAE-Dextran (Sigma #D9885-10G) to increase infectivity. The 
flasks were washed with Hank’s Balanced Salt Solution (HBSS) (Invitrogen) and 
then incubated for 30min at room temperature with 3mL HBSS + 30µg/mL 
DEAE-Dextran. The cells were washed with HBSS and then infected at a 
multiplicity of infection (MOI) of   5-10 IFU (infection forming unit) in 3ml of 
DMEM. The flasks were rocked (two excursions per minute on a Bellco rocker 
platform) for 1 h at room temperature followed by resting for 1 h. Following this, 
the medium was aspirated and replaced with fresh DMEM containing 10% FBS 
and 1 µg/ml cycloheximide (Calbiochem). The infected cells were then transferred 
into a humidified incubator at 37°C/5% CO2 for 48 h. Next, the HeLa cells were 
washed with 10mL PBS, collected by scrapping in 3mL PBS, and then transferred 
into 14-ml round-bottom tubes (Falcon). The tubes (2 ml cell solution/tube) were 
then placed in ice water in a disruptor cup horn of a sonicator (Branson Digital 
Sonicator/S250D). The cells were sonicated at 200 W and 78% amplitude during 
three rounds of 20 s and one last round of 10 s. The cells were then centrifuged for 
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10 min at 200 x g at 4°C. The supernatant was collected and further centrifuged 
for 1 h at 30,000 x g at 4°C in a Sorvall centrifuge. The supernatant from this step 
was discarded and the pellet slowly pipetted up and down to resuspende with 
sucrose-phosphate-glutamate (SPG) buffer (200 mM sucrose, 20 mM NaH2PO4, 
20 mM Na2HPO4, 5 mM L-glutamate, and dH2O (pH 7.2), filtered), aliquoted, and 
stored at  –80°C 
Inclusion-forming unit (IFU) recovery 
 HeLa cells were seeded in a 6-well plate and grown overnight. The cells 
were infected with 1:10 dilutions of Ct EBs in DMEM. After rocking/resting the 
plates for 2 h at room temperature, the medium was replaced with DMEM/10% 
FBS supplemented with 1 µg/ml cycloheximide and the cells were grown for 48h. 
The cells were collected and stained for Ct-LPS and the number of infected cells 
was detected using Flow cytometry (see staining protocol below). The number of 
IFUs per HeLa cell was calculated as follows: using the Poisson distribution, the 
mean number of IFUs infecting the HeLa cells was calculated using the percent 
uninfected cells (Po = e–m). We then multiplied (IFU per cell) by the number of 
cells plated per well to give us the number of IFUs per well. Based on the dilution 
of the stock and the volume used for infection, we determined the total number of 
IFUs in the stock. The following calculation was then performed: total IFUs 
recovered divided by percent infected HeLa cells x total number of HeLa = 
number of IFU recovered per infected cell.  
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Infection of trophoblast cells with Ct 
 Trophoblast cells (1 x 105) were seeded into wells of a 6-well plate and 
allowed to attach overnight. The next day, the cells were washed with 10mL PBS 
and infected at a multiplicity of infection (MOI) of 0.5 - 2 in 2 ml of SPG by 
spinning at 350 x g at 8–10°C for 40 min in a Eppendorf centrifuge with a plate 
holder. This MOI was calculated based on an assay performed using HeLa cells. 
The trophoblast cells were then washed with PBS to remove any unattached 
bacteria. Fresh serum-free OptiMEM (GIBCO-Invitrogen) was then added to the 
plates, and the cells were cultured at 37°C for 12–48 h. 
Intracellular staining and flow cytometry 
 Infection rates in both the trophoblast cells and the HeLa cells were 
analyzed by flow cytometry. Postinfection (24-48h), the cells were washed with 
PBS, detached with 0.05% trypsin-EDTA (Invitrogen), and collected with 
Staining Buffer (SB) (PBS, 1% FBS, and 0.1% sodium azide (NaN3); Sigma-
Aldrich). The suspensions were transferred to a 5-ml polystyrene round-bottom 
tube, snap cap (Falcon; BD Biosciences), and centrifuged at 200 x g for 5 min at 
4°C. The cell pellet was then suspended with SB and centrifuged two more times. 
After this, the cells were fixed in 1 ml of 3.7% formaldehyde (Calbiochem) for 
15–20 min at room temperature. The cells were then centrifuged and washed 
twice in 1 ml of cold Perm/Wash buffer (BD Biosciences #554723) and then 
incubated for 40 min on ice. After this, cells were centrifuged and then 
resuspended in 100 ml of Perm/Wash and add 2-3µg mouse IgG Ab (Jackson 
ImmunoResearch #015-000-002) to block non-specific binding, and incubate for 
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10 min on ice, then add 2 µl of a FITC-conjugated anti-Ct-LPS mAb (ViroStat 
#1649) and incubate for 25 min on ice in the dark. After adding 1 ml of cold 
Perm/Wash buffer and centrifugation, the cells were washed with SB buffer and 
then resuspended in SB. For resuspending pellets, the tubes were gently flicked, 
medium was added, and a quick touch with a vortexer on low speed was 
performed. Cells were analyzed using the FACSCalibur (BD Biosciences). Data 
were acquired using CellQuest (BD Biosciences) and analyzed using FlowJo 
software (Tree Star), respectively.  
Cytokine studies 
 The changes of cytokine/chemokine production in H8-wt vs.DN-MyD88 
trophoblasts infected with Ct were determined by multiplex technology. 
Following infection of trophoblast cells in a 6-well plate with Ct for 12-48 h, the 
culture supernatants were collected and passed through a 13-mm, 0.2-µm pore 
size filter (Pall) to remove cell debris and any EBs. The supernatants were then 
stored at –80°C until analysis was performed. Supernatants were then analyzed for 
a full panel of cytokines and chemokines using the custom Bio-Plex Human 
Cytokine 19-Plex from Bio-Rad with detection and analysis using the Luminex 
100 IS system (Upstate Biotechnology) as recently described [12]. The 19 
cytokines/chemokines analyzed were IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-
10, IL-12p70, IL-13, IL-17, G-CSF, GM-CSF, GRO-α, IFN-γ, MCP-1, MIP-1β, 
RANTES, and TNF-α. The H8 or Sw.71 trophoblasts cytokine production was 
measured by ELISA for human IL-1β (R&D Systems #DLB50), human IL-8 
(Assay Designs #900-156) and human IL-6 (Assay Designs #900-033) following 
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the manufacturer’s protocols on filtered supernatants as described above. The 
samples were read on a BioRad 550 microplate reader and analyzed in Excel. The 
IL-1β secretion by H8 cells was measured using 5x concentrated supernatants 
because the concentration was too low to be aqurately detected by ELISA. The 
supernatants were concentrated using Amicon ultra centrifugal filters with a 10k 
membrane (Millipore #UFC501024).  
Western blot analysis 
 For analysis of intracellular proteins, cells were lysed using 1% Nonidet P-
40 and 0.1% SDS in the presence of protease inhibitors (Roche #11697498001). 
Protein concentrations were calculated by bicinchoninic acid assay (Pierce 
Biotechnology). Proteins were then diluted with gel loading buffer to 20 µg and 
boiled for 5 min. Proteins were resolved under reducing conditions on 12% SDS-
PAGE gels and then transferred onto polyvinylidene difluoride paper 
(PerkinElmer). Membranes were blocked at room temperature for 1 h with 5% fat-
free powdered milk in PBS/0.05% Tween 20 (PBS-T) that was filtered. Following 
three washes for 10 min each with PBS-T, membranes were incubated overnight 
at 4°C with the rabbit anti-human IL-1β Ab (Cell Signaling #2022) that detects 
both the pro-form (31kDa) and the cleaved form (17kDa) of the protein. 
Following this incubation, membranes were washed three times as before and then 
incubated at room temperature for 1 h with the goat anti-rabbit secondary Ab 
conjugated to peroxidase (Vector Laboratories) in PBS-T/1% fat-free powdered 
milk. Following three washes for 10 min each with PBS-T and three washes for 
10 min each with distilled water, the peroxidase-conjugated Ab was detected by 
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ECL (enhanced chemiluminescent substrate) (PerkinElmer). Membranes were 
then stripped and subsequently probed for rabbit anti-human Caspase-1 Ab (Cell 
Signaling #06-503) that detects both the pro-form (45kDa) and the active form 
(20kDa) of the protein and exposed as above. Further the membranes were 
stripped and probed for rabbit-anti-human β-actin Ab (Sigma #A2066) (45kDa).  
For confirming gene knockdown in the shRNA expressing cells rabbit anti-human 
NALP3 Ab (Sigma #HPA012878) (118kDa) and rabbit anti-human ASC Ab 
(Calbiochem #ST1121) (22kDa) were used and the protocols described above 
were used. Images were recorded using the Gel Logic 100 (Kodak) and Kodak MI 
software. 
Statistical analysis 
 Data are expressed as mean ± SD. Statistical significance (p < 0.05) was 
determined using either Student’s t tests or, for multiple comparisons, one-way 
ANOVA followed by Bonferroni’s post-test or multiple regression analyses. For 
all statistical analysis GraphPad Prism 4 was used. All experiments were 
performed at least in triplicate. 
Note: all the above experiments and reagent preparations were performed by 
Crina Boeras with the exceptions below. The Abrahams Lab in the OB-Gyn 
Department at Yale helped run the multiplex cytokine studies and one of the IL-
1β ELISAs. However, the sample acquisition and data analysis was performed by 







Culture of Rifampin-resistant Chlamydia trachomatis serovar D 
 
 Chlamydia trachomatis serovars D and L1 were successfully grown in and 
purified from the HeLa epithelial cell line as described by de la Torre et al. [1] 
and more details are presented in the methods section. The Ct serovar D more 
commonly infects the female genital tract [29] and we wanted to use this serovar 
for all our studies. However, the Ct serovar D was no longer available in our 
laboratory and we received a gift from Dr. Robert DeMars of the Rifampin-
resistant (rif-r) Chlamydia trachomatis serovar D. We have successfully grown 
the Ct rif-r serovar D in HeLa cells and titrated the EB stock as described in detail 
in the methods.  
 Studies done in HeLa cells showed an increased efficiency of infection 
with Ct when the cells were pre-treated with DEAE-Dextran 30µg/ml for 30 min 
at 25ºC prior to the infection. We have either treated the HeLa cells with HBSS 
(Hank’s balanced salt solution) or HBSS+DEAE Dextran prior to the Ct rif-r 
infection and 24h post-infection we have intracellularly stained the cells with a 
chlamydial anti-LPS Ab conjugated to FITC as described in the methods. The 
cells were analyzed by flow cytometry (measured 10.000 events for each sample) 
at 24h post-infection and the rate of infection was determined. The cells treated 
with DEAE-Dextran showed an increase in infection rate by ~20-30% (35% vs. 
48%) compared to the untreated cells (data not shown). These results were 
observed in two individual experiments. When the DEAE-Detran treatment was 
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used to prepare Chlamydia stock, the titers obtained were higher than prior 1-
1.4x108 vs. ~2-5x107 IFU/mL.  
 Rifampin-resistant Chlamydia trachomatis infects first trimester trophoblast 
cells 
 
 Chlamydia trachomatis, which preferentially infects epithelial cells, has 
been shown to also infect a variety of immune cells like monocytes and dendritic 
cells. Recently, de la Torre et al. [1] showed that Chlamydia trachomatis serovars 
D and L1 can infect the first trimester trophoblast cell lines HTR8 (H8) and 
Sw.71. Moreover this infection led to the production of viable infectious EBs that 
could infect trophoblast or HeLa epithelial cells. The infection protocol was 
optimized and was found that centrifuging the Ct serovar D onto the cells leads to 
a higher infection rate in H8 cells (14.4% vs. 67.8%) and Sw.71 cells ( 7.35% vs. 
27.4%) at 36h post-infection [1]. We used the Ct rif-r serovar D (referred to as Ct 
for the remainder of the manuscript) and followed the infection, anti-LPS staining 
and flow cytometry protocols described by de la Torre et al. [1] for all of the 
experiments.   
 H8 and Sw.71 trophoblast cells (1x105) were seeded into wells of a 6-well 
plate and allowed to attach overnight. The next day, the cells were infected with 
Ct at a multiplicity of infection (MOI) of ~1 in 2mL of SPG (Sucrose Phosphate 
Glutamate solution) by spinning at 350xg at 8–10°C for 40 minutes. The 
trophoblast cells were then grown in serum-free OptiMEM at 37°C for 24 –48h. 
Initially the rates of infection in H8 cells were determined by anti-LPS staining 
and flow cytometry at 36h post-infection and ranged between 27-36%, with some 
cell death being observed.  While looking at the cells under a microscope at 24h 
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post-infection we observed the majority (over 50%) of cells had Ct containing 
inclusions, which did not correlate with the rates of infections seen at 36h post-
infection (data not shown). We hypothesized that the Rifampin resistant strain of 
Ct was more aggressive than the regular serovar D, and by 36h post-infection a 
significant number of the infected cells would lyse and could no longer be 
detected by flow cytometry. Another posibility was that the amount of Ct EBs 
used was greater than calculated (MOI ~2) which resulted in an increased 
infection rate and was killing the cells sooner than expected.  
 We therefore decided to compare the rates of infection at 24h and 36h 
post-infection with 2 different MOIs (1 and 2) in the H8 cells. Indeed, we found 
that both the increased MOI and the longer time had an effect on infection rates. 
At MOI=1 there was a significant drop in the measured infection rates between 
24h and 36h at 60.6% vs. 45.5%, and at MOI=2 the infection rates were 81% at 
24h vs. 50% at 36h (data not shown). Moreover, the cell death observed with at 
MOI=2 was significantly reduced when an MOI=1 was used. This supported our 
hypothesis that by 36h the infection rate drops due to cell lysis and release of Ct 
inclusions, and that assaying infection rates at 24h post-infection would give a 
more accurate measurement. Also, the decrease in MOI from 2 to 1, leads to a 
greater cell survival in this more aggressive Ct strain. Similar experiments were 
performed in Sw.71 cells and the same trends were observed.  
 In Figure 1 we show a representative experiment for both H8 and Sw.71 
cells. In panel A. we show the scatter plots for the uninfected (left) and infected 
(right) cells which indicate their size and internal composition. We can observe 
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that in many but not all cells the infection changes their scatter profiles (increased 
side scatter SSC-H on the y-axis) due to the presence of the Ct inclusions. The 
flow cytometry histogram plots (Figure 1.B) show the uninfected cells in red and 
infected cells in blue. The blue graph shows two distinct populations of cells: the 
left-hand peak represents the uninfected cells and the right-hand peak with the 
marker represents the infected trophoblast cell population. The infection rates at 
24h post-infection were 62.1% for H8 cells and 40.1% for Sw.71 cells. Similar 
infection rates were seen in all subsequent experiments. In conclusion, we have 
successfully infected H8 and Sw.71 cells with Ct rif-r serovar D and were able to 
optimize the infection parameters. An adequate MOI to balance infections rate 
and cell death is an effective MOI=1, and the best time to assay the infection 
efficiency by anti-LPS staining and flow cytometry is at 24h post-infection. We 
used these parameters for all our subsequent experiments.  
Ct infection of H8 and Sw.71 trophoblasts induces the production of IL-1β both 
at the mRNA and protein levels 
 
 Recently, de la Torre et al. [1] showed that placental trophoblasts secrete 
pro-inflammatory cytokines like IL-1β and IL-8 after Ct infection. While these 
cells constitutively secrete some IL-8, they do not secrete IL-1β unless stimulated. 
We evaluated the effect of Ct infection on IL-1β production at the transcriptional, 
translational and secreted level in trophoblasts.  
 H8 cells were either non-infected (NI) or infected with Ct at an MOI=1. At 
24h post-infection the cells were lysed and total RNA was extracted. The RNA 
was transcribed into cDNA and the IL-1β mRNA expression was assayed using 




Figure 1.  Infection rates of trophoblast cells infected with Ct by centrifugation. 
H8 and Sw.71 trohpoblasts were infected with Ct at a MOI ~1 by centrifugation. 
At 24h post-infection the cells were stained intracellularly with a FITC-
conjugated mouse anti-Ct LPS mAb. The infection rates were then analyzed by 
flow cytometry.  (A) The flow cytometry dot plots show the side and forward 
scatter of the cells, which indicate their size and internal composition. (B) The 
flow cytometry histogram plots show the uninfected cells in red and infected cells 
in blue. The right-hand peak in the blue graph with the marker represents the 
infected trophoblast cell population.  
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The IL-1β mRNA levels were normalized to the levels of GAPDH mRNA (a 
housekeeping gene) and the results are seen in Figure 2.A. There was a substantial 
(8-10 fold) increase in the IL-1β mRNA levels in the Ct infected compared to the 
non-infected cells with a p<0.01. The experiment was performed in triplicate 
(n=3). 
 Next, we looked at the levels of intracellular IL-1β by western blot. H8 
and Sw.71 cells were either non-infected (NI) or infected with Ct at an MOI=1, 
and at 12h, 24h, 48h post-infection the cells were lysed and protein was extracted.  
The IL-1β levels were analyzed by Western blot using an antibody that recognizes 
both the full-length pro-IL-1β (31kDa) and the processed active IL-1β (17kDa). A 
representative picture of the western blot is shown in Figure 2.B for H8 cells and 
Figure 2.D for Sw.71 cells. The protein bands were analyzed by densitometry and 
the levels were normalized to the corresponding β-actin levels which served as a 
loading control. The relative densitometry data is shown in Figures 2.B and D in 
bar graph format (n=7 for H8 cells, n=3 for Sw.71 cells).  The H8 and Sw.71 have 
none or minimal expression of pro-IL-1β, but there is a significant induction after 
Ct infection as early as 12h post infection with *= p<0.05 or **= p<0.01. While 
the Sw.71 pro-IL-1β induction did not reach significance at 24h and 48h, the 
image shows a definite increase in the levels in the Ct infected cells. Both the H8 
and Sw.71 cells have a small amount of intracellular IL-1β regardless of infection 
status. In the H8 cells by 48h post-infection the levels significantly decrease with 






Figure 2. In trophoblasts Ct infection (MOI~1) induces the production of IL-1β 
mRNA and protein. (A) H8 cells were either uninfected (NI) or infected (Ct) and 
grown for 24h, then IL-1β mRNA levels were assayed by real-time PCR and 
levels were normalized to GAPDH levels. (B) H8 cells were either NI or Ct 
infected and at 12h, 24h, and 48h post infection (PI) protein lysates were made 
and analyzed by Western blot using an IL-1β antibody that detects both the pro 
and active form of the protein. Densitometry of the Pro-IL-1β and IL-1β bands 
was calculated and normalized to the corresponding β-actin levels. The relative 
densitometry graphs are shown. (n=7). (C) The cell-free/EB free supernatants of 
the NI and Ct infected cells from the 12h, 24h, 48h PI time points were analyzed 






Figure 2 (cont.). (D) Sw.71 cells were either uninfected (NI) or infected (Ct) 
and at 12h, 24h, and 48h post infection (PI) protein lysates were made and 
analyzed by Western blot using an IL-1β antibody that detects both the pro and 
active form of the protein. Densitometry of the bands was calculated and 
normalized to β-actin levels and the relative densitometry graphs are shown 
(n=3). (* p<0.05) 
 
 
 To verify this presumption we further analyzed the cell supernatants for 
IL-1β by ELSIA. The cell free/EB free supernatants from the NI or Ct infected H8 
cells from all time points (12h, 24h and 48h post-infection) were collected and 
analyzed. Figure 2.C shows the levels of secreted IL-1β.  The uninfected cells do 
not secrete any of their intracellular IL-1β while the Ct infected cells start 
processing and secreting IL-1β at 24h and by 48h post-infection there is a 
significant increase in IL-1β secretion p<0.01 (n=7). This correlates with the 
western blot data.  
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Generation of a stably transfected DN-MyD88 cell line  
 
 TLR-2 and TLR-4 have been shown to recognize chlamydial LPS in 
immune cells like macrophages and dendritic cells [17-18]. Also in genital tract 
epithelial cells infected with Chlamydia, TLR-2 and its adapter protein MyD88 
have been shown to be recruited to the chlamydial inclusion membrane and be 
required for the production of IL-8 [20]. Studies have shown that both TLR-2 and 
TLR-4 signal through the adapter protein MyD88.  Thus, we wanted to investigate 
the potential role for these TLRs in inducing an inflammatory response in Ct 
infected trophoblasts. We wanted to block the action of MyD88 and assay the 
secretion of cytokines after Ct infection.  
 We stably transfected H8 cells with the pDeNy expression plasmid 
containing the human DN-MyD88 (dominant negative) construct as described in 
detail in the methods section. The DN-MyD88 (aa 161-296) seen in Figure 3.A 
contains a truncated form of MyD88 that has the C-terminal TIR domain but lacks 
the death domain (DD) and is unable to homodimerize and activate the signaling 
cascade. The cells expressing DN-MyD88 were selected using the antibiotic 
Zeocin at 1000µg/mL for 10-14 days. Untransfected cells served as H8 wild-type 
controls. The antibiotic selected cells were then cloned by limiting dilution and 
cultured further.  
 As seen in Figure 3.B, supernatants from H8 cells and five of the DN-
MyD88 individual clones referred to as C1C5 were tested for IL-8 levels by 
ELISA after stimulation for 72h with the IIC5 antibody (20µg/mL). The IIC5 Ab. 
has been shown to induce a MyD88 dependent IL-8 response in trophoblasts 
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[59g]. Since the IL-8 production was shown to be MyD88 dependent, a decreased 
production of IL-8 from a given clone would suggest a functional DN-MyD88 
construct. The IL-8 levels in the unstimulated clones were normalized to match 
the baseline of the unstimulated H8 cells and the treated cells were adjusted by the 
same factor. The clones with the least IL-8 induction, C3 (374µg/mL) and C5 
(358µg/mL) (black bars), compared to H8 cells (624µg/mL) were selected for 
further analysis.  
 H8 cells and the DN-MyD88 cells (C3 and C5) were either non-infected 
(NI) or Ct infected with an MOI=1. At 48h post infection the cell-free/EB free 
supernatants were collected and analyzed for IL-8 by ELISA (n=3) and the results 
are shown in Figure 3.C. The baseline IL-8 level in the non-infected DN-MyD88 
cells (C3 and C5) was normalized to match that of the non-infected H8 cells. At 
48h post infection the IL-8 response in the C3 and C5 cells was significantly 
lower than H8 cells, with p<0.05 and p<0.01 respectively, suggesting an efficient 
knockdown of the MyD88 function. We used the C5 clone for our next 
experiments. To further prove that these cells are truly DN-MyD88 in the furutre 
we can also stimulate them with LPS and look for NFkB pathway activation 






Figure 3. Selection of DN-MyD88 cell lines using a functional approach. (A) 
The dominant negative (DN) MyD88 has the TIR domain that interacts with the 
TLRs, but lacks the death domain (DD) that leads to downstream signaling. (B) 
H8 cells and 5 different clones (C1 thru C5) of DN-MyD88 cells were treated 
with 20µM IIC5 Ab (which induces a MyD88 dependent IL-8 response) for 72h 
and the supernatants were analyzed for IL-8 by ELSIA. The clones with the least 
IL-8 induction (C3 and C5) compared to wt H8 cells were analyzed further. (C) 
H8 cells and DN-MyD88 cells (C3 and C5) were either NI or Ct infected at 
MOI~1. At 48h post infection cell-free/EB free supernatants were collected and 
analyzed for IL-8 by ELISA (n=3). The baseline IL-8 secretion in the NI cells was 
normalized to match that of the NI wt H8 cells. The IL-8 response in the DN-
MyD88 (C3, C5) cells was significantly lower than the wt H8 suggesting an 
efficient knockdown of MyD88. (* =p<0.05, ** = p<0.01) 
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Chlamydia trachomatis rif-r infects DN-MyD88 trophoblasts 
  
 After we have generated and selected functional clones for DN-MyD88 
cells (as described above) we wanted to see if suppressing the MyD88 function 
might interfere with the ability of Chlamydia to infect these trophoblast cells.  
H8 and DN-MyD88 trohpoblasts were infected with Ct at a MOI =1 by 
centrifugation as described in the methods section. At 24h post-infection the cells 
were stained intracellularly with an anti-chlamydial LPS mAb that is FITC-
conjugated. The infection rates were then analyzed by flow cytometry. 
 In Figure 4 we show a representative experiment for both H8 and DN-
MyD88 cells. In panel A. we show the scatter plots for the uninfected (left) and 
infected (right) cells which indicate their size and internal composition. We can 
observe that the infection increases the side scatter (on the y-axis) due to the 
presence of the Ct inclusions within both H8 and DN-MyD88. The flow 
cytometry histogram plots (Figure 4.B) show two distinct populations of cells, the 
uninfected cells in red and infected cells in blue. In the blue graphs the right-hand 
peak with the marker represents the infected trophoblast cell population. The 
infection rates at 24h post-infection were 62.1% for H8 cells and 64.3% for DN-
MyD88 cells. Similar infection rates were seen in all subsequent experiments. We 
have successfully infected the H8 and the DN-MyD88 cells with Ct rif-r serovar 
D. The knockdown of MyD88 does not seem to affect the infectibility of the cells. 
The infection rates were similar and there was no increased cell death seen in the 





Figure 4. Infection rates of H8 and DN-MyD88 trophoblast cells infected with 
Ct by centrifugation. H8 and DN-MyD88 trohpoblasts were infected with Ct at a 
MOI~1 by centrifugation. At 24h post-infection the cells were stained 
intracellularly with a FITC-conjugated mouse anti-Ct LPS mAb. The infection 
rates were then analyzed by flow cytometry.  (A) The flow cytometry dot plots 
show the side and forward scatter of the cells which indicate their size and 
internal composition. (B) The flow cytometry histogram plots show the 
uninfected cells in red and infected cells in blue. In the blue graph the right-hand 




IL-1β production in H8 trophoblast cells after Chlamydia infection is 
independent of MyD88 
 
 We generated a functional DN-MyD88 cell line and wanted to test if the 
production of IL-1β resulting from the Ct infection was mediated through a 
MyD88 dependent TLR such as TLR-2 or TLR-4. We decided to explore this at 
the mRNA level, the intracellular protein level and the secreted cytokine level. 
 H8 and DN-MyD88 cells were either non-infected (NI) or infected with Ct 
at an MOI=1. At 24h post-infection the cells were lysed and total RNA was 
extracted. The RNA was transcribed into cDNA and the IL-1β mRNA expression 
was assayed using quantitative PCR (QPCR) as described in detail in the 
methods. The IL-1β mRNA levels were normalized to the levels of GAPDH 
mRNA and the results are seen in Figure 5.A. In both the H8 cells (as shown in 
figure 2) and DN-MyD88 cells there was a substantial (8-10 fold) increase in the 
IL-1β mRNA levels in the Ct infected cells compared to the non-infected cells 
with a p<0.01 for H8 and p<0.05 for DN-MyD88. The experiment was performed 
in triplicate (n=3). This showed that the inhibition of MyD88 did not affect the 
induction of IL-1β mRNA after Ct infection.  
 We then looked at the secreted cytokine levels in response to Ct infection 
in H8 vs. DN-MyD88 cells. The cells were non-infected or infected with MOI=1 
and cell/EB free supernatants were collected at 48h post infection. The samples 
were analyzed by multiplex technology for 19 cytokines/chemokines. Of these 
factors, the levels of the pro-inflammatory cytokines IL-1β, IL-8 and IL-6 were of 
interest to us. In Figure 5.B we see the levels of secreted IL-1β at 48h post-
infection of both H8 and DN-MyD88 cells. As seen at the mRNA level, there is a 
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significant induction in IL-1β production after Ct infection in both cell types (H8 
p<0.01, DN-MyD88 p<0.05) (n=3). However there is no difference in the ability 
to produce IL-1β between the H8 cells and the DN-MyD88 cells suggesting that 




















Figure 5. Cytokine profiles of H8 and DN-MyD88 cells with Ct infection 
(MOI~1). (A) H8 and DN-MyD88 cells were either uninfected (NI) or infected 
(Ct) and grown for 24h, then IL-1β mRNA levels were assayed by real-time PCR 
and levels were normalized to GAPDH levels (n=3). H8 and DN-MyD88 cells 
were either uninfected (NI) or infected (Ct) and grown for 48h, then the cell-
free/EB-free supernatants were analyzed for cytokines by Luminex/multiplex 
analysis. Bar graphs show the levels of (B) secreted IL-1β or (C) IL-6 and IL-8 
after NI or Ct infection (n=3). (* p<0.05, ** p<0.01, ***p<0.001) 
 
 The DN-MyD88 cells have already been selected for reduced IL-8 
production (as described in the prior section) and the results seen on Figure 5.C in 
the right panel confirm this. We see a significant induction of IL-8 production 
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after Ct infection in both H8 and DN-MyD88 cells as compared to non-infected 
cells (H8 p<0.001, DN-MyD88 p<0.01). However, the DN-MyD88 infected cells 
have a 5 fold reduced response compared to the H8 infected cells (p<0.001) 
(n=3). In the left panel we see the effect of Ct infection and inhibition of MyD88 
on IL-6 production which is also thought to be MyD88 dependent. There is a 
moderate induction of IL-6 with Ct infection in H8 cells (p<0.01), but a 
significant decrease in IL-6 production in DN-MyD88 cells (p<0.01). This 
suggests that the IL-6 production in trophoblasts is MyD88 dependent.  
 Next we looked at the levels of intracellular IL-1β in the cells we collected 
the supernatants from. H8 and DN-MyD88 cells were either non-infected (NI) or 
infected with Ct at an MOI=1, and at 12h, 24h, 48h post-infection protein was 
extracted. The IL-1β levels were analyzed by Western blot. A representative 
picture of the western blot is shown in Figure 5.D. The protein levels were 
normalized to the corresponding β-actin levels and the relative densitometry data 
is shown in bar graph format (n=7 for H8 cells, n=3 for DN-MyD88 cells). The 
H8 and DN-MyD88 have none or minimal expression of pro-IL-1β, but there is a 
significant induction after Ct infection as early as 12h post infection, with *= 
p<0.05 or **= p<0.01. This induction increases further by 24h and 48h post 
infection. While the DN-MyD88 pro-IL-1β induction did not reach significance at 
24h and 48h, the image shows a definite increase in the levels in the Ct infected 
cells. Both the H8 and DN-MyD88 cells have a small amount of intracellular IL-
1β regardless of infection status. These results support the fact that the production 
of IL-1β after Ct infection is independent of MyD88 and possibly TLR-2 and 
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TLR-4. Another possibility is that a very small of MyD88 activity is sufficient for 
IL-1 β production, while a larger amount is needed for IL-8 and IL-6.  
 
 
Figure 5 (Cont). Cytokine profiles of H8 and DN-MyD88 cells with Ct 
infection (MOI~1). (D) H8 (top) and DN-MyD88 (bottom) cells were either NI or 
Ct infected and at 12h, 24h, and 48h post infection (PI) protein lysates were made 
and analyzed by Western blot using an IL-1β antibody that detects both the pro 
and active form of the protein. Densitometry of the Pro-IL-1β and IL-1β bands 
was calculated and normalized to the corresponding β-actin levels. The relative 
densitometry graphs are shown (n=3). (*p<0.05, **p<0.01) 
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The trohpoblasts’ response to increased extracellular KCl suggests a role for 
NLRs (NALP3) in their IL-1β induction upon Ct infection  
 
 Activation of the inflammasome leads to the activation of Caspase-1 and 
the subsequent processing of pro-inflammatory cytokines like IL-1β, IL-18 and 
IL-33. One of the best studied inflammasomes, the NALP3 inflammasome, is 
activated in response to microbial stimuli including LPS, MDP, bacterial RNA as 
well as endogenous molecules like uric acid crystals, silica and ATP [33]. 
Exposure to extracellular ATP leads to the opening of a cation channel (P2X7R) 
and release of intracellular potassium and NALP3 inflammasome activation. 
Conversely, increased levels of extracellular potassium block the ion efflux and 
the NALP-3-mediated caspase-1 activation [33-34].  
  We wanted to investigate if the NALP-3 inflammasome is involved in the 
processing of the IL-1β produced by trophoblasts after Ct infection. Therefore we 
decided to expose the trophoblasts to increased extracellular KCl (potassium) and 
look at IL-1β secretion. First we determined the effect of the extra KCl on cell 
survival. As seen in Figure 6.A we incubated both H8 and Sw.71 cells with media 
containing increasing amounts of KCl (50mM, 70mM and 90mM) for 36h and 
then measured cell viability/survival. The untreated cells were considered to have 
100% survival and the treated cells’ survival was expressed as a percentage of this 
number. The cells had a linear increase in death with increasing amounts of KCl, 
but at 50mM the survival was unaffected. We used 50mM KCl in our subsequent 
experiments.  
 H8 and Sw.71 cells were either non-infected or infected with Ct at MOI~1 
and 50mM KCl was added to the media after infection. The cells were incubated 
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for 36h and then the cell free/EB free supernatants were the assayed for the levels 
of IL-1β by ELISA. (n=3). As seen in Figure 6.B the increased extracellular KCl 
significantly inhibited the secretion of IL-1β in both H8 and Sw.71 cells 
compared with the untreated cells (* p<0.05, ** p<0.01). This suggests that the 
reduced ionic gradient resulted from the higher KCl outside the cells precluded 
the activation of the NALP-3 inflammasome and reduced the caspase-1 activity 
that is needed for IL-1β secretion.  
 
Figure 6.  In trohpoblasts the response to increased extracellular KCl suggests a 
role for NLRs in the IL-1β induction upon Ct infection. (A) H8 and Sw.71 cells 
were incubated with increasing amounts of KCl (50mM 90mM) in the media 
for 36h. Cell viability was assayed and plotted with non- treated cells representing 
100%. (B) H8 and Sw.71 cells were infected with Ct at MOI~1 and 50mM KCl 
was added to the media after infection. The cells were incubated for 36h and then 
the levels of IL-1β from the supernatants were measured by ELISA. (n=3). The 
KCl treatment inhibited the secretion of IL-1β in both H8 and Sw.71 cells 
compared with the untreated cells. (* p<0.05, ** p<0.01, *** p<0.001) 
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Chlamydia infection of placental trophoblasts causes some changes in active 
caspase-1 levels 
  
 Caspase-1 is the only protease known to process the pro-IL-1β into its 
active form that gets secreted and exerts its biological functions. As mentioned 
above, caspase-1 is present as an inactive zymogen and it requires the assembly of 
an inflammasome to be able to oligomerize and become activated [22,33]. 
Trophoblast cells have been shown to express small amounts of active caspase-1 
without stimulation, however we wanted to investigate if infection with 
Chlamydia would lead to an increase in the active caspase-1 levels, which would 
in turn result in the increased levels of secreted IL-1β we observed.  
 We looked at the levels of intracellular active caspase-1 by western blot. 
H8 and Sw.71 cells were either non-infected (NI) or infected with Ct at an 
MOI=1, and at 12h, 24h, 48h post-infection protein was extracted.  The caspase-1 
levels were analyzed with an antibody that detects the cleaved form of the protein. 
A representative picture of the western blot is shown in Figure 7.A for both the 
H8 cells (top) and Sw.71 cells (bottom). The protein bands were normalized to the 
corresponding β-actin levels and the relative densitometry data is shown in 
Figures 7.B in bar graph format. (n=7 for H8 cells, n=3 for Sw.71 cells). As 
described before, we observe that both H8 and Sw.71 cells express active caspase-
1 at baseline. The infection with Ct resulted in an increase in active caspse-1 in 
H8 cells at 12h post-infection (*p<0.05), equal levels at 24h and a significant 
decrease in the levels by 48h post infection (*p<0.05). This response was not seen 
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in the Sw.71 cells where the levels of active caspase-1 remained largely 
unchanged.  
 
Figure 7.  In trophoblasts Ct infection (MOI~1) induces slight changes in active 
Caspase-1 levels. (A) H8 and Sw.71 cells were either uninfected (NI) or infected 
(Ct) and at 12h, 24h, and 48h post infection protein lysates were made and 
analyzed by Western blot using a Caspase-1 antibody that detects the active form 
of the protein. (B) Densitometry of the Caspase-1 bands was calculated and 
normalized to the corresponding β-actin levels. The relative densitometry graphs 





 The placental trophoblast cells are the first line of defense at the maternal-
fetal interface and they express TLRs and NLRs in order to detect invading 
pathogens and mount a rapid and effective immune response. They are distinctive 
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cells in that they constitutively secrete chemokines like IL-8, MCP-1 and GRO-α 
which recruit monocytes and macrophages in the absence of a threat [11, 35]. 
They are responsible for modulating the immune response to ensure that the 
“foreign” fetus is not attacked by the mother’s immune system. These cells are 
also thought to play a role in trophoblast invasion and remodeling of the spiral 
arteries to ensure adequate placental development [11,35]. However, in the 
presence of pathogens like Chlamydia these resident immune cells could become 
infected and activated and further contribute to the inflammatory response.  
 Previously published studies from our laboratory showed that Chlamydia 
trachomatis serovar D successfully infected two first trimester trophoblast cell 
lines, H8 which was transformed with SV40 large T Antigen, and Sw.71 which 
was immortalized by retroviral transduction of the telomerase gene [1]. The 
infection resulted in a change in the cytokines and chemokines produced by the 
trophoblasts. Most notably was the induction of the pro-inflammatory cytokine 
IL-1β, and the increase in the levels of the constitutively secreted IL-8 and IL-6 
[1]. Our results confirm the IL-1β, IL-8 and IL-6 cytokine secretion after Ct 
infection, and further demonstrate that Chlamydia induces the transcription of IL-
1β mRNA, the translation of intracellular pro-IL-1β as early as 12h post infection 
and the processing and secretion of active IL-1β starting at 24h. While the 
production of IL-8 and IL-6 after Chlamydia infection is mediated through 
MyD88, the induction of the pro-inflammatory cytokine IL-1β is independent of 
MyD88. Further we demonstrated that preventing activation of the NALP3 
inflammasome by blocking K+ efflux from cells inhibited IL-1β secretion in both 
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H8 and Sw.71 cells suggesting a role for NLRs and inflammasomes in mediating 
this immune response.  
 While de la Torre et al. (2009) [1] saw minimal cell death until 72h post-
infection; in our studies we observed an increase in cell death, presumably due to 
lysis and EB release as early as 48h post-infection. Chlamydia has been shown to 
block apoptosis in order to complete its life cycle. The differences seen are likely 
due to the use of a rifampin resistant strain of Chlamydia serovar D, which is 
more aggressive in invading both trophoblasts and HeLa cells, and was observed 
to complete its life cycle faster. As a result we focused most of our studies in the 
first 48h after infection.  
 Chlamydia trachomatis had antigenically diverse surface proteins and can 
be recognized by multiple TLRs. Some studies show that both chlamydial LPS 
and the Ct-HSP60 protein stimulate TLR-4 [36] and through the activation of 
caspases it leads to trophoblast apoptosis [37]. However, chlamydial LPS can also 
signal through TLR-2 [19], and infection with the whole organism also leads to 
TLR-2 activation [36]. While in animal macrophages TLR-2 stimulation by Ct 
leads to IL-6 and TNF-α production [17], in human epithelial cells we see an up-
regulation of IL-8 [20]. This IL-8 response had been shown to be mediated 
through TLR-2 and its associated adapter protein MyD88, which are recruited to 
the Chlamydia inclusion membrane. The presence of a dominant negative (DN) 
form of MyD88 results in a reduction in the IL-8 levels [20]. This is consistent 
with our data in trophoblasts that showed a reduction in IL-8 secretion in all the 
DN-MyD88 clones in response to both the anti-phospholipid antibody (IIC5) 
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stimulation and Chlamydia infection. This suggests that the DN-MyD88 construct 
is functional in our cells. To further substantiate that these cells are truly MyD88 
dominant negative we can also stimulate them with LPS and look at the NFkB 
activation, or look for the DN-MyD88 plasmid expression in these cells. We 
observed a decrease in the IL-6 production in the DN-MyD88 cells which points 
to a MyD88 dependent TLR, like TLR-2, for mediating the IL-8 and IL-6 
secretion by trophoblasts after a Chlamydia infection. 
 IL-1β is a potent pro-inflammatory cytokine that is released by 
trophoblasts after Chlamydia infection. In this study we demonstrated that Ct 
induces the transcription of IL-1β mRNA and the subsequent translation of pro-
IL-1β. These processes are thought to be mediated through the NFkB or MAPK 
pathways in response to a microbial stimulus propagated through PRRs [42]. In 
addition to TLRs, other PRRs like the NODs can also activate the NFkB pathway 
and lead to transcription of pro-inflammatory genes. In human macrophages, 
stimulation of TLR-4 with LPS resulted in induction of IL-1β mRNA and pro-IL-
1β [38] which are mediated through the adapter protein MyD88 and the activation 
of the NFkB pathway. Moreover, MyD88 is believed to be essential for inducing 
an immune response to Chlamydia infections [36], and while we confirmed this 
for the secretion of IL-8 and IL-6, MyD88 did not play a role in the production of 
IL-1β by trophoblasts. Knocking down MyD88 in H8 cells had no effect on the 
induction of IL-1β mRNA, nor on the levels of intracellular pro-IL-1β or the 
secreted active-IL-1β. This suggests that MyD88 dependent TLRs are either not 
stimulated by Chlamydia, or the stimulation does not result in the initiation of IL-
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1β production. Another possibility is that the induction of IL-1β requires minimal 
MyD88 activity and a complete inhibition of MyD88 was not achieved. The IL-8 
secretion is MyD88 dependent which could be a result of direct stimulation of 
TLR-2 by Ct, or a secondary response mediated by the action of the secreted IL-
1β on the IL-1 receptor, which can also associate with and signal through MyD88.  
 The other potential players in the induction of IL-1β are the NLRs, like the 
intracellular NOD receptors. The NOD proteins have a C-terminal LRR domain 
able to recognize PAMPs, a central NOD domain that allow their self-
oligomerization and an N-terminal CARD domain that allows them to interact 
with caspases [21]. NOD1 and NOD2 are present in the cytosol and recognize 
bacterial products that result from the degradation of peptidoglycan [12]. NOD1 is 
an ubiquitous receptor for peptidoglycan from gram negative bacteria, and 
Chlamydia was shown to stimulate the NOD1 receptor and activate the NFkB 
pathway in epithelial cells [21]. The H8 trophoblasts express NOD1 and upon its 
activation they secrete IL-8 and IL-6 suggesting that NOD1 is functional in these 
cells [23]. The expression of NOD1 in turn is up-regulated through TLR-4 
stimulation by LPS and depicts a close relationship between the different PRRs in 
mediating an inflammatory response [23]. Therefore, the IL-1β transcription and 
translation in H8 cells infected with Chlamydia could be mediated through NOD1 
and further studies could shed more light on the exact mechanisms involved.  
 IL-1β depends for its processing and secretion on the activity of caspase-1. 
Caspase-1 activation can occur upon the assembly and activation of an 
inflammasome, which is a complex of proteins that contains a sensor NLR (like 
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NALP1, NALP3 or IPAF), the adapter ASC and pro-caspase-1. Inflamamsomes 
are thought to first undergo ”priming” (transcriptional up-regulation of their 
components) mediated through NFkB or sometimes TNF in response to stimuli 
such as bacterial infections, and then assembly into the active forms [22]. 
Monocytes and macrophages infected with Chlamydia have been shown to secrete 
caspase-1 dependent IL-1β, and to assemble inflammasomes for its processing 
[26]. Recent studies in HeLa cervical epithelial cells showed that infection with 
Chlamydia trachomatis leads to caspase-1 activation and this process is dependent 
on the activation of the NALP-3 inflammasome and the presence of the adapter 
ASC [26]. The NALP-3 inflammasome can be activated in response to a variety 
of molecules, but K+ efflux from cells seems to be one of the main up-stream 
events. The inhibition of K+ efflux by increased extracellular potassium (KCl) 
resulted in reduced caspase-1 levels and presumably reduced NALP-3 
inflammasome activation in epithelial cells [26]. This study however could not 
study the role of the NLAP-3 inflammasome on IL-1β secretion since the 
epithelial cells do not produce this cytokine.  
 As we observed an up-regulation of pro-IL-1β and the accumulation of 
intracellular IL-1β in our Ct infected trophoblast cells, we wanted to investigate 
whether the NALP-3 inflammasome and caspase-1 play a role in this process. Our 
results show a statistically significant decrease in IL-1β production in both H8 
and Sw.71 trophoblast cells infected with Chlamydia when the cells are incubated 
with high extracellular KCl and the NALP-3 inflammasome activation is 
inhibited. This suggests a role for the NALP-3 inflammasome in the IL-1β 
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processsing in trophoblast cells after Ct infection, which is consistent with studies 
done in other cell types. To further test if the KCl treatments truly inhibited the 
NALP3 activation we can also look at the activation of caspase-1 or the 
production of IL-1β in response to known NALP3 activators like ATP in the 
presence of high KCL levels. 
 To further substantiate the role of NALP-3 and ASC in inducing IL-1β in 
trophoblasts we pursued studies to knock down the function of these proteins by 
using shRNA technology. The shRNA constructs transfected into the cells would 
bind to the NALP-3 or ASC mRNA and target it for degradation thus lowering the 
levels of the expressed proteins. We used shRNA constructs obtained from Dr. 
Jenny Ting, which showed a NALP-3 and ASC dependent IL-1β immune 
response to the influenza-A virus in monocytes [39]. In Sw.71 trophoblast cells 
there was more than 50% reduction of mRNA for both ASC and NALP-3; 
however there was no reduction in the levels of NALP-3 protein. ASC protein 
levels were reduced by 40-50%, however this was not sufficient to observe an 
effect on the production of IL-1β (data not shown). We are now pursuing the use 
of commercially available shRNA constructs from Sigma as described in [26] to 
obtain more efficient protein knockdown. If NALP-3 and ASC prove not to be the 
major mediators of IL-1β processing in the trophoblast cells, another possibility is 
the NLRC4/IPAF inflammasome which can assemble and lead to caspase-1 
activation in the absence of ASC [22]. The IPAF inflammasome is activated by 
flagelin and other components of gram negative bacteria that have type III 
secretion systems such as Chlamydia, [43] which make IPAF it a likely candidate.  
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 While it was shown that Ct induces the activation of caspase-1 in 
epithelial cells [26], the levels of active caspase-1 obtained in our western blot 
analysis showed only a modest increase in the H8 infected cells, and no change in 
the Sw.71 cells. The discrepancy can be due to the fact that the trophoblasts 
constitutively express caspase-1 and these low levels of constitutive caspase-1 
present in the cells could be sufficient for the processing of the pro-IL-1β induced 
by Chlamydia infection. The constitutive caspase-1 activation could also be 
responsible for the presence of active IL-1β seen in these cells at baseline. Further 
studies looking at active caspase-1 levels by other methods or inhibiting the 
activity of caspase-1 would help determine the requirement for caspase-1 
activation in the IL-1β secretion by trophoblasts. 
 The processing and secretion of IL-1β is thought to be tightly coupled and 
occur is fast succession in the presence of a stimulus that activates an 
inflamamsome [22].  However, we observed that both the uninfected and infected 
H8 and Sw.71 trophoblast cells have intracellular IL-1β, but only the infected 
cells secrete it. This suggests yet another signal requirement/checkpoint for the 
secretion of this highly potent inflammatory cytokine. The trophoblasts appear to 
make and store small amounts of IL-1β to have readily available for secretion in 
the case of a pathogen invasion. The secretion mechanisms for IL-1β are still 
poorly understood, and IL-1β does not have the hydrophobic signal sequence 
required for entering the classical secretory pathway involving the endoplasmic 
reticulum and the Golgi apparatus [27]. A non-classical pathway hypothesized to 
result in IL-1β secretion involves exocytosis from secretory lysosomes, shedding 
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of plasma membrane microvesicles and export through the plasma membrane 
using specialized transporters [27]. This wide variety of mechanisms involved 
offers the opportunity for pathogens like Chlamydia to act and modulate the 
secretion of IL-1β or other cytokines.  
 In summary we have shown that Chlamydia is able to induce IL-1β 
mRNA transcription in a MyD88 independent manner in trophoblasts, which is a 
novel observation and is not consistent with mechanisms described in other cell 
types. Secondly we have some evidence that processing of pro-IL-1β occurs 
through the NALP-3 inflammasome. Thirdly, Chlamydia infection can stimulate 
the secretion of active-IL-1β from trophoblast cells. This last observation 
uncovers yet another step at which Chlamydia can act and modulate the immune 
response in trophoblast cells. The requirement of at least two separate signals to 
produce and secrete inflammatory cytokines like IL-1β highlights the close 
relationships between the different receptors and pathways in ensuring a tight 
regulation of pro-inflammatory immune responses.  
 In a normal pregnancy the immune system plays the critical task of 
protecting the fetus from the constant threat posed by pathogens while limiting the 
effects of the mother’s immune response on the fetus itself. Both viral and 
bacterial infections have been linked to preterm labor, spontaneous abortions [3] 
and intrauterine growth restriction [40,41]. Moreover, evidence of intrauterine 
inflammation and chorioamnionitis was noted in up to 85% of placentas from 
preterm deliveries even when the amniotic fluid cultures were negative [16]. 
Chlamydia trachomatis is one of the organisms detected in the deciduas and 
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placentas from complicated pregnancies [5, 7, 8]. The placental trophoblasts 
attract a variety of immune cells to the maternal-fetal interface in response to 
pathogens like Chlamydia, and an amplified inflammatory response, as seen by 
the secretion of IL-1β, can lead to initiation of early parturition. The inflammation 
and scarring of the upper genital tract after Chlamydia infections has also been 
well documented and it can prevent implantation and further successful 
pregnancies. Through the many mechanisms Chlamydia possesses to modulate 
the immune system, as described above for IL-1β, it can have a negative impact 
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